CHRISTEL WHEELER: Open Payments
NPI 1588133003 · DECATUR, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,449 in 130 payments from 39 companies in 2025. Trend: 2023 $6,694 · 2024 $4,192 · 2025 $3,449
Food & beverage: $3,250Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $544 |
| AstraZeneca Pharmaceuticals LP | 16 | $434 |
| Incyte Corporation | 6 | $279 |
| ABBVIE INC. | 12 | $275 |
| Daiichi Sankyo Inc. | 8 | $187 |
| Lilly USA, LLC | 10 | $168 |
| Merck Sharp & Dohme LLC | 8 | $154 |
| Eisai Inc. | 4 | $114 |
| Ipsen Biopharmaceuticals, Inc | 2 | $113 |
| Astellas Pharma US Inc | 3 | $95 |
Products named: EPKINLY, RYBREVANT, ENHERTU, IMFINZI, KEYTRUDA, VERZENIO, Monjuvi, DARZALEX.
Industry payments across IL — which companies pay providers there.
